Varnitrip
Varenicline tablets for smoking cessation. It lessens nicotine cravings and withdrawal symptoms.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 0.5mg | 10 tablets | $93.00 | $9.30 |
| 0.5mg | 20 tablets | $134.00 | $6.70 |
| 0.5mg | 30 tablets | $143.00 | $4.77 |
| 0.5mg | 60 tablets | $239.00 | $3.98 |
| 0.5mg | 90 tablets | $322.00 | $3.58 |
| 0.5mg | 120 tablets | $400.00 | $3.33 |
| 0.5mg | 180 tablets | $555.00 | $3.08 |
| 0.5mg | 270 tablets | $722.00 | $2.67 |
| 0.5mg | 360 tablets | $872.00 | $2.42 |
| 1mg | 10 tablets | $133.00 | $13.30 |
| 1mg | 20 tablets | $223.00 | $11.15 |
| 1mg | 30 tablets | $311.00 | $10.37 |
| 1mg | 60 tablets | $462.00 | $7.70 |
| 1mg | 90 tablets | $607.00 | $6.74 |
| 1mg | 120 tablets | $790.00 | $6.58 |
| 1mg | 180 tablets | $1094.00 | $6.08 |
| 1mg | 270 tablets | $1506.00 | $5.58 |
| 1mg | 360 tablets | $1823.00 | $5.06 |
- Category
- Addiction Recovery
- Active ingredient
- Varenicline
- Route
- Oral use
- Form
- Tablet
- Strengths
- 0.5mg · 1mg
No prescription needed: we place your order for Varnitrip on your behalf.
Varnitrip details
- Condition
- Smoking Cessation
- Alternative names
- varenicline
- Therapeutic class
- Partial Nicotinic Acetylcholine Receptor Agonist
- Pharmacological class
- Smoking Cessation Agent
- Contraindications
- history of severe psychiatric disorders; severe renal impairment
- Minor side effects
- nausea; headache; insomnia
- Moderate side effects
- vivid dreams; flatulence; fatigue
- Dosage forms
- Tablet
- Administration route
- Oral use
- Manufacturer
- Tripada Healthcare
- Onset time
- 1–2 weeks
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Alcohol
- Age restrictions
- Approved for adults over eighteen years.
Serious side effects
severe depression and suicidal ideation, requires immediate medical attention; seizure activation, requires immediate medical attention
Patient summary
Varenicline tablets for smoking cessation. It lessens nicotine cravings and withdrawal symptoms.
Mechanism of action
Binds selectively to neuronal alpha-4-beta-2 nicotinic receptors, exerting partial agonist effects to block nicotine reward mechanisms.
Pregnancy and breastfeeding
Pregnancy: Use if potential benefits outweigh risks. Breastfeeding: Consult a clinician.